Sulfasalazine

This classification denotes a sulfonamide anti-infective agent with the molecular formula C18H14N4O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 3XC8GUZ6CB, chemically known as salicylic acid, 5-((p-(2-pyridylsulfamoyl)phenyl)azo)- but more generally known as sulfasalazine, which bears US NIH Compound Identifier 5353980. European Medicines Agency schedules Sulfasalazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10727MIG. The term SULFASALAZINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). World Health Organization schedules sulfasalazine in its Anatomical Therapeutic Chemical (ATC) Classification. SULFASALAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule sulfasalazine under HS 29350090 and SITC 51580. As of Q4 2014, SULFASALAZINE remains US FDA's Preferred Term for this commodity. Sulfasalazine bears US NLM identifiers UMLS ID C0036078 and NCI Concept Code C29469. SMILES: S(=O)(=O)(NC1NCCCC1)C1CCC(N/N=C2/C=C(C(=O)C=C2)C(=O)O)CC1.